Click for best price
Preventable Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Preventable Vaccines Market
The global Preventable Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preventable Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preventable Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preventable Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preventable Vaccines market.
Global Preventable Vaccines Scope and Market Size
Preventable Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Preventable Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Segment by Application
Bacterial Diseases
Virus Diseases
By Company
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Preventable Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Preventable Vaccines, with price, sales, revenue, and global market share of Preventable Vaccines from 2019 to 2022.
Chapter 3, the Preventable Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preventable Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Preventable Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Preventable Vaccines.
Chapter 13, 14, and 15, to describe Preventable Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Preventable Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Preventable Vaccines Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
128 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Preventable Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Preventable Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Market by Application
1.3.1 Global Preventable Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Preventable Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Preventable Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Preventable Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Preventable Vaccines Sales by Region
2.4.1 Global Preventable Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Preventable Vaccines by Region (2023-2028)
2.5 Global Preventable Vaccines Revenue by Region
2.5.1 Global Preventable Vaccines Revenue by Region (2017-2022)
2.5.2 Global Preventable Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Preventable Vaccines Sales by Manufacturers
3.1.1 Global Top Preventable Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Preventable Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Preventable Vaccines in 2021
3.2 Global Preventable Vaccines Revenue by Manufacturers
3.2.1 Global Preventable Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Preventable Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Preventable Vaccines Revenue in 2021
3.3 Global Preventable Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Preventable Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Preventable Vaccines Sales by Type
4.1.1 Global Preventable Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Preventable Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Preventable Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Preventable Vaccines Revenue by Type
4.2.1 Global Preventable Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Preventable Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Preventable Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Preventable Vaccines Price by Type
4.3.1 Global Preventable Vaccines Price by Type (2017-2022)
4.3.2 Global Preventable Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Preventable Vaccines Sales by Application
5.1.1 Global Preventable Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Preventable Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Preventable Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Preventable Vaccines Revenue by Application
5.2.1 Global Preventable Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Preventable Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Preventable Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Preventable Vaccines Price by Application
5.3.1 Global Preventable Vaccines Price by Application (2017-2022)
5.3.2 Global Preventable Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Preventable Vaccines Market Size by Type
6.1.1 North America Preventable Vaccines Sales by Type (2017-2028)
6.1.2 North America Preventable Vaccines Revenue by Type (2017-2028)
6.2 North America Preventable Vaccines Market Size by Application
6.2.1 North America Preventable Vaccines Sales by Application (2017-2028)
6.2.2 North America Preventable Vaccines Revenue by Application (2017-2028)
6.3 North America Preventable Vaccines Market Size by Country
6.3.1 North America Preventable Vaccines Sales by Country (2017-2028)
6.3.2 North America Preventable Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Preventable Vaccines Market Size by Type
7.1.1 Europe Preventable Vaccines Sales by Type (2017-2028)
7.1.2 Europe Preventable Vaccines Revenue by Type (2017-2028)
7.2 Europe Preventable Vaccines Market Size by Application
7.2.1 Europe Preventable Vaccines Sales by Application (2017-2028)
7.2.2 Europe Preventable Vaccines Revenue by Application (2017-2028)
7.3 Europe Preventable Vaccines Market Size by Country
7.3.1 Europe Preventable Vaccines Sales by Country (2017-2028)
7.3.2 Europe Preventable Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Preventable Vaccines Market Size by Type
8.1.1 Asia Pacific Preventable Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Preventable Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Preventable Vaccines Market Size by Application
8.2.1 Asia Pacific Preventable Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Preventable Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Preventable Vaccines Market Size by Region
8.3.1 Asia Pacific Preventable Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Preventable Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Preventable Vaccines Market Size by Type
9.1.1 Latin America Preventable Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Preventable Vaccines Revenue by Type (2017-2028)
9.2 Latin America Preventable Vaccines Market Size by Application
9.2.1 Latin America Preventable Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Preventable Vaccines Revenue by Application (2017-2028)
9.3 Latin America Preventable Vaccines Market Size by Country
9.3.1 Latin America Preventable Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Preventable Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Preventable Vaccines Market Size by Type
10.1.1 Middle East and Africa Preventable Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Preventable Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Preventable Vaccines Market Size by Application
10.2.1 Middle East and Africa Preventable Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Preventable Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Preventable Vaccines Market Size by Country
10.3.1 Middle East and Africa Preventable Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Preventable Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Corporation Information
11.6.2 Takeda Pharmaceutical Overview
11.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Takeda Pharmaceutical Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Takeda Pharmaceutical Recent Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Overview
11.7.3 Abbott Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Roche Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AstraZeneca Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Corporation Information
11.10.2 Mitsubishi Tanabe Pharma Overview
11.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mitsubishi Tanabe Pharma Recent Developments
11.11 Lupin
11.11.1 Lupin Corporation Information
11.11.2 Lupin Overview
11.11.3 Lupin Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lupin Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lupin Recent Developments
11.12 Serum Institute of India
11.12.1 Serum Institute of India Corporation Information
11.12.2 Serum Institute of India Overview
11.12.3 Serum Institute of India Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Serum Institute of India Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Serum Institute of India Recent Developments
11.13 LG Life Sciences
11.13.1 LG Life Sciences Corporation Information
11.13.2 LG Life Sciences Overview
11.13.3 LG Life Sciences Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 LG Life Sciences Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 LG Life Sciences Recent Developments
11.14 S K Chemicals
11.14.1 S K Chemicals Corporation Information
11.14.2 S K Chemicals Overview
11.14.3 S K Chemicals Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 S K Chemicals Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 S K Chemicals Recent Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Overview
11.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shenzhen Kangtai Biological Products Recent Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Overview
11.16.3 Sinovac Biotech Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sinovac Biotech Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sinovac Biotech Recent Developments
11.17 Janssen Pharmaceuticals
11.17.1 Janssen Pharmaceuticals Corporation Information
11.17.2 Janssen Pharmaceuticals Overview
11.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Janssen Pharmaceuticals Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Janssen Pharmaceuticals Recent Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Overview
11.18.3 Crucell Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Crucell Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Crucell Recent Developments
11.19 Bavarian Nordic
11.19.1 Bavarian Nordic Corporation Information
11.19.2 Bavarian Nordic Overview
11.19.3 Bavarian Nordic Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Bavarian Nordic Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Bavarian Nordic Recent Developments
11.20 Baxter
11.20.1 Baxter Corporation Information
11.20.2 Baxter Overview
11.20.3 Baxter Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Baxter Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Baxter Recent Developments
11.21 Bharat Biotech
11.21.1 Bharat Biotech Corporation Information
11.21.2 Bharat Biotech Overview
11.21.3 Bharat Biotech Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Bharat Biotech Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Bharat Biotech Recent Developments
11.22 Dynavax
11.22.1 Dynavax Corporation Information
11.22.2 Dynavax Overview
11.22.3 Dynavax Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Dynavax Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Dynavax Recent Developments
11.23 Bausch Health
11.23.1 Bausch Health Corporation Information
11.23.2 Bausch Health Overview
11.23.3 Bausch Health Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Bausch Health Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Bausch Health Recent Developments
11.24 Protein Sciences
11.24.1 Protein Sciences Corporation Information
11.24.2 Protein Sciences Overview
11.24.3 Protein Sciences Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Protein Sciences Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Protein Sciences Recent Developments
11.25 Panacea Biotec
11.25.1 Panacea Biotec Corporation Information
11.25.2 Panacea Biotec Overview
11.25.3 Panacea Biotec Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Panacea Biotec Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Panacea Biotec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Preventable Vaccines Industry Chain Analysis
12.2 Preventable Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Preventable Vaccines Production Mode & Process
12.4 Preventable Vaccines Sales and Marketing
12.4.1 Preventable Vaccines Sales Channels
12.4.2 Preventable Vaccines Distributors
12.5 Preventable Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Preventable Vaccines Industry Trends
13.2 Preventable Vaccines Market Drivers
13.3 Preventable Vaccines Market Challenges
13.4 Preventable Vaccines Market Restraints
14 Key Findings in The Global Preventable Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Preventable Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Adult Preventable Vaccines
Table 3. Major Manufacturers of Pediatric Preventable Vaccines
Table 4. Global Preventable Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Preventable Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Preventable Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Preventable Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Preventable Vaccines Sales by Region (2023-2028) & (K Units)
Table 9. Global Preventable Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Preventable Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Preventable Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Preventable Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Preventable Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Preventable Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Preventable Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Preventable Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Preventable Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Preventable Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Preventable Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Preventable Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2021)
Table 21. Preventable Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Preventable Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Preventable Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 26. Global Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 27. Global Preventable Vaccines Sales Share by Type (2017-2022)
Table 28. Global Preventable Vaccines Sales Share by Type (2023-2028)
Table 29. Global Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Preventable Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Preventable Vaccines Revenue Share by Type (2023-2028)
Table 33. Preventable Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Preventable Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 36. Global Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 37. Global Preventable Vaccines Sales Share by Application (2017-2022)
Table 38. Global Preventable Vaccines Sales Share by Application (2023-2028)
Table 39. Global Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Preventable Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Preventable Vaccines Revenue Share by Application (2023-2028)
Table 43. Preventable Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Preventable Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 46. North America Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 47. North America Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 50. North America Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 51. North America Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 54. North America Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 55. North America Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 58. Europe Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 59. Europe Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 62. Europe Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 63. Europe Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 66. Europe Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 67. Europe Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Preventable Vaccines Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Preventable Vaccines Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Preventable Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Preventable Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Major Businesses
Table 107. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. GlaxoSmithKline Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GlaxoSmithKline Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Merck Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck Recent Developments
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Major Businesses
Table 117. Novartis Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Novartis Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novartis Recent Developments
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Major Businesses
Table 122. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Pfizer Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Pfizer Recent Developments
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Major Businesses
Table 127. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Sanofi Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sanofi Recent Developments
Table 130. Takeda Pharmaceutical Corporation Information
Table 131. Takeda Pharmaceutical Description and Major Businesses
Table 132. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Takeda Pharmaceutical Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Takeda Pharmaceutical Recent Developments
Table 135. Abbott Corporation Information
Table 136. Abbott Description and Major Businesses
Table 137. Abbott Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Abbott Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Abbott Recent Developments
Table 140. Roche Corporation Information
Table 141. Roche Description and Major Businesses
Table 142. Roche Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Roche Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Roche Recent Developments
Table 145. AstraZeneca Corporation Information
Table 146. AstraZeneca Description and Major Businesses
Table 147. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. AstraZeneca Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. AstraZeneca Recent Developments
Table 150. Mitsubishi Tanabe Pharma Corporation Information
Table 151. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 152. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Mitsubishi Tanabe Pharma Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Mitsubishi Tanabe Pharma Recent Developments
Table 155. Lupin Corporation Information
Table 156. Lupin Description and Major Businesses
Table 157. Lupin Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Lupin Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Lupin Recent Developments
Table 160. Serum Institute of India Corporation Information
Table 161. Serum Institute of India Description and Major Businesses
Table 162. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 163. Serum Institute of India Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Serum Institute of India Recent Developments
Table 165. LG Life Sciences Corporation Information
Table 166. LG Life Sciences Description and Major Businesses
Table 167. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 168. LG Life Sciences Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. LG Life Sciences Recent Developments
Table 170. S K Chemicals Corporation Information
Table 171. S K Chemicals Description and Major Businesses
Table 172. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 173. S K Chemicals Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. S K Chemicals Recent Developments
Table 175. Shenzhen Kangtai Biological Products Corporation Information
Table 176. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 177. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 178. Shenzhen Kangtai Biological Products Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Shenzhen Kangtai Biological Products Recent Developments
Table 180. Sinovac Biotech Corporation Information
Table 181. Sinovac Biotech Description and Major Businesses
Table 182. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 183. Sinovac Biotech Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Sinovac Biotech Recent Developments
Table 185. Janssen Pharmaceuticals Corporation Information
Table 186. Janssen Pharmaceuticals Description and Major Businesses
Table 187. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 188. Janssen Pharmaceuticals Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Janssen Pharmaceuticals Recent Developments
Table 190. Crucell Corporation Information
Table 191. Crucell Description and Major Businesses
Table 192. Crucell Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 193. Crucell Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Crucell Recent Developments
Table 195. Bavarian Nordic Corporation Information
Table 196. Bavarian Nordic Description and Major Businesses
Table 197. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 198. Bavarian Nordic Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Bavarian Nordic Recent Developments
Table 200. Baxter Corporation Information
Table 201. Baxter Description and Major Businesses
Table 202. Baxter Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 203. Baxter Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Baxter Recent Developments
Table 205. Bharat Biotech Corporation Information
Table 206. Bharat Biotech Description and Major Businesses
Table 207. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 208. Bharat Biotech Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Bharat Biotech Recent Developments
Table 210. Dynavax Corporation Information
Table 211. Dynavax Description and Major Businesses
Table 212. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 213. Dynavax Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Dynavax Recent Developments
Table 215. Bausch Health Corporation Information
Table 216. Bausch Health Description and Major Businesses
Table 217. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 218. Bausch Health Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 219. Bausch Health Recent Developments
Table 220. Protein Sciences Corporation Information
Table 221. Protein Sciences Description and Major Businesses
Table 222. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 223. Protein Sciences Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 224. Protein Sciences Recent Developments
Table 225. Panacea Biotec Corporation Information
Table 226. Panacea Biotec Description and Major Businesses
Table 227. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 228. Panacea Biotec Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 229. Panacea Biotec Recent Developments
Table 230. Key Raw Materials Lists
Table 231. Raw Materials Key Suppliers Lists
Table 232. Preventable Vaccines Distributors List
Table 233. Preventable Vaccines Customers List
Table 234. Preventable Vaccines Market Trends
Table 235. Preventable Vaccines Market Drivers
Table 236. Preventable Vaccines Market Challenges
Table 237. Preventable Vaccines Market Restraints
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventable Vaccines Product Picture
Figure 3. Global Preventable Vaccines Market Share by Type in 2021 & 2028
Figure 3. Adult Preventable Vaccines Product Picture
Figure 4. Pediatric Preventable Vaccines Product Picture
Figure 5. Global Preventable Vaccines Market Share by Application in 2021 & 2028
Figure 6. Bacterial Diseases
Figure 7. Virus Diseases
Figure 8. Preventable Vaccines Report Years Considered
Figure 9. Global Preventable Vaccines Sales 2017-2028 (K Units)
Figure 10. Global Preventable Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Preventable Vaccines Revenue 2017-2028 (US$ Million)
Figure 12. Global Preventable Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Preventable Vaccines Sales Market Share by Region (2017-2022)
Figure 14. Global Preventable Vaccines Sales Market Share by Region (2023-2028)
Figure 15. North America Preventable Vaccines Sales YoY (2017-2028) & (K Units)
Figure 16. North America Preventable Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Preventable Vaccines Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Preventable Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Preventable Vaccines Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Preventable Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Preventable Vaccines Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Preventable Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Preventable Vaccines Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Preventable Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Preventable Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Preventable Vaccines in the World: Market Share by Preventable Vaccines Revenue in 2021
Figure 27. Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Preventable Vaccines Sales Market Share by Type (2017-2028)
Figure 29. Global Preventable Vaccines Revenue Market Share by Type (2017-2028)
Figure 30. Global Preventable Vaccines Sales Market Share by Application (2017-2028)
Figure 31. Global Preventable Vaccines Revenue Market Share by Application (2017-2028)
Figure 32. North America Preventable Vaccines Sales Market Share by Type (2017-2028)
Figure 33. North America Preventable Vaccines Revenue Market Share by Type (2017-2028)
Figure 34. North America Preventable Vaccines Sales Market Share by Application (2017-2028)
Figure 35. North America Preventable Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. North America Preventable Vaccines Sales Share by Country (2017-2028)
Figure 37. North America Preventable Vaccines Revenue Share by Country (2017-2028)
Figure 38. U.S. Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Preventable Vaccines Sales Market Share by Type (2017-2028)
Figure 41. Europe Preventable Vaccines Revenue Market Share by Type (2017-2028)
Figure 42. Europe Preventable Vaccines Sales Market Share by Application (2017-2028)
Figure 43. Europe Preventable Vaccines Revenue Market Share by Application (2017-2028)
Figure 44. Europe Preventable Vaccines Sales Share by Country (2017-2028)
Figure 45. Europe Preventable Vaccines Revenue Share by Country (2017-2028)
Figure 46. Germany Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 47. France Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Preventable Vaccines Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Preventable Vaccines Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Preventable Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Preventable Vaccines Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Preventable Vaccines Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Preventable Vaccines Revenue Share by Region (2017-2028)
Figure 57. China Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. India Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Preventable Vaccines Sales Market Share by Type (2017-2028)
Figure 67. Latin America Preventable Vaccines Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Preventable Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Latin America Preventable Vaccines Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Preventable Vaccines Sales Share by Country (2017-2028)
Figure 71. Latin America Preventable Vaccines Revenue Share by Country (2017-2028)
Figure 72. Mexico Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Preventable Vaccines Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Preventable Vaccines Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Preventable Vaccines Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Preventable Vaccines Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Preventable Vaccines Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Preventable Vaccines Revenue Share by Country (2017-2028)
Figure 82. Turkey Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Preventable Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Preventable Vaccines Value Chain
Figure 86. Preventable Vaccines Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
